MedTrace Logo

Adult Congenital Heart Disease Registry (QuERI)

NCT01659411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2025-02-03

No results posted yet for this study

Summary

Multi-center, observational, U.S.-based longitudinal program. Data will be collected prospectively for 3 years. Individual physician feedback will be provided on data collected with the purpose of improving the management of patients - quality enhancement research initiative (QuERI) process from adult patients enrolled with a history of repaired Congenital Heart Disease (CHD).

Conditions

Interventions

OTHER

Observational

Yearly clinical visits

Sponsors & Collaborators

  • Canadian Heart Research Centre

    collaborator OTHER

  • Actelion

    lead INDUSTRY

Principal Investigators

  • Michael Landzberg, MD · Harvard Medical School / Boston Adult Congenital Heart

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-01
Primary Completion
2018-05-16
Completion
2018-05-16

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01659411 on ClinicalTrials.gov